SCHEMBL6430908

SCHEMBL6430908

O=C(c1cccc2ccccc12)N1CCCC1

nearest known ligand 0.97

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.68
LMNA P02545 2/20 0.68
USP2 O75604 1/20 0.62
HPGD P15428 3/20 0.61
POLB P06746 3/20 0.61
HTT P42858 1/20 0.61
KDM4E B2RXH2 3/20 0.59
GAA P10253 2/20 0.59
MAPT P10636 2/20 0.59
AVPR1A P37288 1/20 0.59
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
HIF1A Q16665 1/20 0.57
GLA P06280 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
TSHR P16473 1/20 0.56
RECQL P46063 1/20 0.56
TGM2 P21980 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8407368 0.98 ALDH1A1 (0.66) ALDH1A1LMNAUSP2HPGDPOLB
SCHEMBL11360223 0.98 ALDH1A1 (0.66) ALDH1A1LMNAUSP2HPGDPOLB
SCHEMBL28570849 0.98 ALDH1A1 (0.66) ALDH1A1LMNAUSP2HPGDPOLB
SCHEMBL14720666 0.98 ALDH1A1 (0.66) ALDH1A1LMNAUSP2HPGDPOLB
SCHEMBL28394623 0.98 ALDH1A1 (0.66) ALDH1A1LMNAUSP2HPGDPOLB
SCHEMBL25247976 0.98 ALDH1A1 (0.66) ALDH1A1LMNAUSP2HPGDPOLB
SCHEMBL4453090 0.93 ALDH1A1 (0.77) ALDH1A1LMNAUSP2POLBHTT
SCHEMBL3582934 0.86 ALDH1A1 (0.68) ALDH1A1LMNAUSP2POLBHTT
SCHEMBL8577381 0.86 ALDH1A1 (0.57) ALDH1A1LMNAUSP2HPGDPOLB
SCHEMBL3518475 0.85 ALDH1A1 (0.67) ALDH1A1LMNAUSP2HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1590359-A2 PARTIAL AND FULL AGONISTS OF A sb 1 /sb ADENOSINE RECEPTORS CV Therapeutics Inc. (US) 2005-11-02 EP disclosed
WO-2004069185-A2 PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS CV THERAPEUTICS INC. (US) 2004-08-19 WO disclosed
US-6531612-B2 Pyrrolidine-2-carboxylic acid cyano-methyl amide derivatives useful for treating diseases associated with cystein proteases, such as osteoporosis, osteoarthritis, rheumatoid arthritis, tumor metastasis, glomerulonephritis HOFFMAN-LA ROCHE INC. 2003-03-11 US disclosed